clenbuterol has been researched along with Muscle Contraction in 62 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The drug (a beta2-adrenoceptor agonist) was administered daily for six weeks by gastric gavage (10 microg/kg body weight), interrupted every 5 days by a 2 day omission of dosing to avoid drug desensitization." | 5.31 | Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury. ( Berry, MS; Fitton, AR; McGregor, AD, 2001) |
| "Clenbuterol is a β2 -adrenergic receptor agonist known to induce skeletal muscle hypertrophy and a slow-to-fast phenotypic shift." | 3.81 | Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery. ( Bonnieu, A; Candau, RB; Cazorla, O; Chopard, A; Douillard, A; Galbès, O; Lacampagne, A; Lionne, C; Philippe, AG; Py, G; Ramonatxo, C; Sanchez, AM; Sirvent, P, 2015) |
| "Bacteria were infused into the uteri of 5 estrous mares resistant to persistent mating-induced endometritis, first during a control cycle, and then during treatment with clenbuterol, a beta 2 agonist." | 3.70 | Uterine contractility is necessary for the clearance of intrauterine fluid but not bacteria after bacterial infusion in the mare. ( Nikolakopoulos, E; Watson, ED, 1999) |
| " Spontaneous detrusor muscle contractions were unaffected by glibenclamide (K(ATP) channel blocker) but were reduced when pinacidil (K(ATP) channel opener) concentrations exceeded 10(-5) M." | 3.70 | K(ATP) channels mediate the beta(2)-adrenoceptor agonist-induced relaxation of rat detrusor muscle. ( Elliott, RA; Hudman, D; Norman, RI, 2000) |
| "We examined the effects of four beta 2-agonists, clenbuterol, metaproterenol, procaterol, and albuterol, on the contractility of fatigued canine diaphragm." | 3.68 | Effects of beta 2-agonists on the contractility of fatigued canine diaphragm in vivo. ( Miyashita, A; Numata, H; Okubo, T; Suzuki, M; Suzuki, S, 1993) |
| "Clenbuterol has been used to alleviate chronic obstructive pulmonary disease and elicit an anabolic response in muscles." | 1.42 | Negative effect of clenbuterol on physical capacities and neuromuscular control of muscle atrophy in adult rats. ( Bisson, JF; Dernoncourt, V; Lang, G, 2015) |
| " These pharmacodynamic properties, and stronger lipophilic properties shown by the two compounds may result in increased cardiovascular risk for consumers of illicitly treated animals." | 1.32 | New beta-adrenergic agonists used illicitly as growth promoters in animal breeding: chemical and pharmacodynamic studies. ( Boatto, G; Brambilla, G; Daniele, C; Loizzo, A; Manca, G; Mazzanti, G, 2003) |
| "Clenbuterol is a beta2-adrenoceptor agonist primarily used for treating bronchospasm and alleviating the symptoms of chronic obstructive pulmonary disease (COPD) in the horse." | 1.32 | Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses. ( Kearns, CF; Lynch, GS; McKeever, KH; Plant, DR, 2003) |
| "Clenbuterol treatment increased fiber cross-sectional area (CSA) by 6% and maximal isometric force (P(o)) by 20% in extensor digitorum longus (EDL) muscles, whereas fiber CSA in soleus muscles decreased by 3% and P(o) was unchanged, compared with untreated controls." | 1.31 | Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. ( Gregorevic, P; Lynch, GS; Plant, DR; Ryall, JG; Sillence, MN, 2002) |
| " The presence of 10(-5) M ICI 118, 551, beta(2)-adrenoceptor antagonist, shifted significantly the clenbuterol dose-response to 1 Hz electrical field stimulation (EC(50) 3." | 1.31 | Inhibition of the contractile response of the rat detrusor muscle by the beta(2)-adrenoceptor agonist clenbuterol. ( Elliott, RA; Hudman, D; Norman, RI, 2000) |
| "Clenbuterol treatment did not increase the normalized force or power output of diaphragm strips from either mdx or control mice." | 1.31 | Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment. ( Faulkner, JA; Hinkle, RT; Lynch, GS, 2001) |
| " The drug (a beta2-adrenoceptor agonist) was administered daily for six weeks by gastric gavage (10 microg/kg body weight), interrupted every 5 days by a 2 day omission of dosing to avoid drug desensitization." | 1.31 | Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury. ( Berry, MS; Fitton, AR; McGregor, AD, 2001) |
| " In addition, 6 rats per group were dosed orally with 2 microg x kg(-1) clenbuterol daily acutely (1 dose) or chronically (1 dose daily for 8 days), or with distilled water to serve as controls." | 1.31 | Inhibition of the contractile responses of isolated human and rat bladders by clenbuterol. ( Elliott, RA; Hudman, D; Norman, RI; Sandhu, DP; Terry, TR; Whitaker, P, 2001) |
| "Clenbuterol treatment significantly increased the relative mass (P<0." | 1.30 | Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol. ( Hayes, A; Williams, DA, 1998) |
| "3." | 1.30 | Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles. ( Faulkner, JA; Hinkle, RT; Lynch, GS, 1999) |
| "Clenbuterol was more potent than isoproterenol in increasing EFS-induced contractile force in the external urethral sphincter, whereas isoproterenol was more potent than clenbuterol in increasing EFS-induced contractile force in the extensor digitorum longus." | 1.29 | Effects of clenbuterol on rabbit vesicourethral muscle contractility. ( Kihara, K; Kishimoto, T; Morita, T; Nagamatsu, H; Oshima, H, 1995) |
| "(+)-Clenbuterol was at least 1,000 times less potent in this respect." | 1.27 | Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of clenbuterol. ( Waldeck, B; Widmark, E, 1985) |
| "Clenbuterol (Contraspasmin, Spiropent) was used to treat threatened delivery in a dosage of three times 0." | 1.27 | [Effect of the oral beta-mimetic drug clenbuterol (Contraspasmin, Spiropent) and orally and intravenously administered Partusisten on the rheobase]. ( Jäger, KH; Niedner, W; Wagner, F; Weisbach, W, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (14.52) | 18.7374 |
| 1990's | 23 (37.10) | 18.2507 |
| 2000's | 21 (33.87) | 29.6817 |
| 2010's | 8 (12.90) | 24.3611 |
| 2020's | 1 (1.61) | 2.80 |
| Authors | Studies |
|---|---|
| Pozzoli, C | 1 |
| Bertini, S | 1 |
| Poli, E | 1 |
| Placenza, G | 1 |
| Menozzi, A | 1 |
| Kim, J | 1 |
| Grotegut, CA | 1 |
| Wisler, JW | 1 |
| Li, T | 1 |
| Mao, L | 1 |
| Chen, M | 1 |
| Chen, W | 1 |
| Rosenberg, PB | 1 |
| Rockman, HA | 1 |
| Lefkowitz, RJ | 1 |
| Lang, G | 1 |
| Dernoncourt, V | 1 |
| Bisson, JF | 1 |
| Sirvent, P | 2 |
| Douillard, A | 2 |
| Galbes, O | 2 |
| Ramonatxo, C | 2 |
| Py, G | 2 |
| Candau, R | 1 |
| Lacampagne, A | 2 |
| Sanchez, AM | 1 |
| Philippe, AG | 1 |
| Lionne, C | 1 |
| Bonnieu, A | 1 |
| Chopard, A | 1 |
| Cazorla, O | 1 |
| Candau, RB | 1 |
| Woodall, BP | 1 |
| Woodall, MC | 1 |
| Luongo, TS | 1 |
| Grisanti, LA | 1 |
| Tilley, DG | 1 |
| Elrod, JW | 1 |
| Koch, WJ | 1 |
| McCormick, C | 1 |
| Alexandre, L | 1 |
| Thompson, J | 1 |
| Mutungi, G | 1 |
| Head, SI | 2 |
| Ha, TN | 1 |
| Duarte, T | 1 |
| Menezes-Rodrigues, FS | 1 |
| Godinho, RO | 1 |
| Dodd, SL | 2 |
| Koesterer, TJ | 1 |
| Ryall, JG | 1 |
| Gregorevic, P | 2 |
| Plant, DR | 2 |
| Sillence, MN | 1 |
| Lynch, GS | 7 |
| Mazzanti, G | 1 |
| Daniele, C | 1 |
| Boatto, G | 1 |
| Manca, G | 1 |
| Brambilla, G | 1 |
| Loizzo, A | 1 |
| Kearns, CF | 1 |
| McKeever, KH | 1 |
| Picquet, F | 1 |
| De-Doncker, L | 1 |
| Falempin, M | 1 |
| Hinkle, RT | 4 |
| Dolan, E | 1 |
| Cody, DB | 1 |
| Bauer, MB | 1 |
| Isfort, RJ | 1 |
| George, I | 1 |
| Xydas, S | 1 |
| Mancini, DM | 1 |
| Lamanca, J | 1 |
| DiTullio, M | 1 |
| Marboe, CC | 1 |
| Shane, E | 1 |
| Schulman, AR | 1 |
| Colley, PM | 1 |
| Petrilli, CM | 1 |
| Naka, Y | 1 |
| Oz, MC | 1 |
| Maybaum, S | 1 |
| Frossard, N | 1 |
| Landry, Y | 1 |
| Grüneberger, A | 1 |
| Geier, G | 1 |
| Schilt, R | 1 |
| Hooijerink, H | 1 |
| Huf, FA | 1 |
| Zuiderveld, OP | 1 |
| Bast, A | 1 |
| Numata, H | 1 |
| Suzuki, S | 1 |
| Miyashita, A | 1 |
| Suzuki, M | 1 |
| Okubo, T | 1 |
| Zeman, RJ | 2 |
| Zhang, Y | 1 |
| Etlinger, JD | 2 |
| Yamanishi, T | 1 |
| Yasuda, K | 1 |
| Tojo, M | 1 |
| Hattori, T | 1 |
| Sakakibara, R | 1 |
| Shimazaki, J | 1 |
| Maltin, CA | 2 |
| Delday, MI | 2 |
| Watson, JS | 1 |
| Heys, SD | 1 |
| Nevison, IM | 1 |
| Ritchie, IK | 1 |
| Gibson, PH | 1 |
| Radda, GK | 1 |
| Morita, T | 3 |
| Kihara, K | 1 |
| Nagamatsu, H | 1 |
| Oshima, H | 1 |
| Kishimoto, T | 3 |
| Powers, SK | 2 |
| Vrabas, IS | 1 |
| Criswell, D | 1 |
| Stetson, S | 1 |
| Hussain, R | 1 |
| Hayes, A | 3 |
| Campbell, SP | 1 |
| Williams, DA | 4 |
| Jiang, TX | 1 |
| Cairns, A | 1 |
| Road, JD | 1 |
| Wilcox, PG | 1 |
| Encabo, A | 1 |
| Ferrer, M | 1 |
| Salaíces, M | 1 |
| Manso, R | 1 |
| Marín, J | 2 |
| Balfagón, G | 2 |
| Belloli, C | 2 |
| Re, G | 1 |
| Arioli, F | 2 |
| Badino, P | 1 |
| Carcano, R | 2 |
| Odore, R | 1 |
| Girardi, C | 1 |
| Beretta, C | 2 |
| Bakker, AJ | 1 |
| Wareham, AC | 2 |
| Stephenson, DG | 1 |
| Van Der Heijden, HF | 1 |
| Dekhuijzen, PN | 1 |
| Folgering, H | 1 |
| Ginsel, LA | 1 |
| Van Herwaarden, CL | 1 |
| Petrou, M | 1 |
| Clarke, S | 1 |
| Morrison, K | 1 |
| Bowles, C | 1 |
| Dunn, M | 1 |
| Yacoub, M | 1 |
| Faulkner, JA | 3 |
| Ricart-Firinga, C | 1 |
| Stevens, L | 1 |
| Canu, MH | 1 |
| Nemirovskaya, TL | 1 |
| Mounier, Y | 1 |
| Nikolakopoulos, E | 1 |
| Watson, ED | 1 |
| Hudman, D | 3 |
| Elliott, RA | 3 |
| Norman, RI | 3 |
| Iizuka, H | 1 |
| Iwata, T | 1 |
| Kondo, S | 1 |
| Chen, KD | 2 |
| Alway, SE | 2 |
| Fitton, AR | 1 |
| Berry, MS | 1 |
| McGregor, AD | 1 |
| Guldner, NW | 1 |
| Klapproth, P | 1 |
| Grossherr, M | 1 |
| Brügge, A | 1 |
| Sheikhzadeh, A | 1 |
| Tölg, R | 1 |
| Rumpel, E | 1 |
| Noel, R | 1 |
| Sievers, HH | 1 |
| Whitaker, P | 1 |
| Terry, TR | 1 |
| Sandhu, DP | 1 |
| Lavoie, JL | 1 |
| Calderone, A | 1 |
| Béliveau, L | 1 |
| Smith, WN | 1 |
| Dirks, A | 1 |
| Sugiura, T | 1 |
| Muller, S | 1 |
| Scarpace, P | 1 |
| Okamiya, Y | 2 |
| Hoshina, K | 1 |
| Takeshita, T | 2 |
| Agbenyega, ET | 1 |
| Lagente, V | 1 |
| Lefort, J | 1 |
| Vargaftig, BB | 1 |
| Aoki, K | 1 |
| Naruchi, T | 1 |
| Waldeck, B | 1 |
| Widmark, E | 1 |
| Mirbahar, KB | 1 |
| Eyre, P | 1 |
| Ludemann, R | 1 |
| Easton, TG | 1 |
| Reeds, PJ | 1 |
| Hay, SM | 1 |
| Smith, FG | 1 |
| Lobley, GE | 1 |
| Weisbach, W | 1 |
| Niedner, W | 1 |
| Wagner, F | 1 |
| Jäger, KH | 1 |
2 trials available for clenbuterol and Muscle Contraction
| Article | Year |
|---|---|
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support.
Topics: Adrenergic beta-Agonists; Body Composition; Cardiac Output, Low; Clenbuterol; Dose-Response Relation | 2006 |
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients.
Topics: Adult; Clenbuterol; Double-Blind Method; Humans; Knee Joint; Male; Menisci, Tibial; Muscle Contracti | 1993 |
60 other studies available for clenbuterol and Muscle Contraction
| Article | Year |
|---|---|
Relaxing effects of clenbuterol, ritodrine, salbutamol and fenoterol on the contractions of horse isolated bronchi induced by different stimuli.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Bronchi; Bronchodilator Agents; Clenbuterol | 2020 |
β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; beta-Arrestin 1; Calcium Signaling; Cells, Cultured; C | 2018 |
Negative effect of clenbuterol on physical capacities and neuromuscular control of muscle atrophy in adult rats.
Topics: Analysis of Variance; Animals; Bronchodilator Agents; Clenbuterol; Disease Models, Animal; Explorato | 2015 |
Effects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Signaling; Calpain; Clenbuterol; Homeostasis; Ma | 2014 |
Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
Topics: Action Potentials; Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Calcium; Clenbutero | 2015 |
Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy.
Topics: Animals; Clenbuterol; G-Protein-Coupled Receptor Kinase 2; Hypertrophy; Mice; Mice, Knockout; Muscle | 2016 |
Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Calcium-Bindin | 2010 |
Acute inhibitory effects of clenbuterol on force, Ca²⁺ transients and action potentials in rat soleus may not involve the β₂-adrenoceptor pathway.
Topics: Action Potentials; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Calciu | 2011 |
Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle.
Topics: Adenosine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Clenbuterol; Colf | 2012 |
Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Calcium-Transporting ATPases; Clenbuterol; Disease M | 2002 |
Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
Topics: Adrenal Glands; Adrenergic beta-Agonists; Animals; Clenbuterol; Fenoterol; Heart; Male; Muscle Contr | 2002 |
New beta-adrenergic agonists used illicitly as growth promoters in animal breeding: chemical and pharmacodynamic studies.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animal Feed; Animals; Atrial Function; Benzen | 2003 |
Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Clenbuterol; Horses; Male; Muscle Contraction; Muscle Fi | 2003 |
Enhancement of hybrid-fiber types in rat soleus muscle after clenbuterol administration during hindlimb unloading.
Topics: Animals; Clenbuterol; Hindlimb Suspension; Male; Muscle Contraction; Muscle Fibers, Skeletal; Muscle | 2004 |
Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Analysis of Variance; Animals; Clenbu | 2005 |
Comparative effects of beta-agonists on central and peripheral rat airways.
Topics: Animals; Carbachol; Clenbuterol; Ethanolamines; Lung; Male; Metaproterenol; Muscle Contraction; Musc | 1983 |
[Treatment of Motor urge incontinence with Clenbuterol (author's transl)].
Topics: Adult; Clenbuterol; Ethanolamines; Female; Humans; Middle Aged; Muscle Contraction; Urinary Incontin | 1982 |
Screening of cattle urine samples for the presence of beta-agonists with a functional test: some preliminary results.
Topics: Adrenergic beta-Agonists; Animals; Cattle; Chromatography, Ion Exchange; Clenbuterol; Guinea Pigs; I | 1994 |
Effects of beta 2-agonists on the contractility of fatigued canine diaphragm in vivo.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Blood Pressure; Clenbuterol; Diaphragm; Dogs; Dose-Res | 1993 |
Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Gamma Rays; Hindlimb; Male; Mice; Mice, Inbred mdx; | 1994 |
Effects of beta 2-stimulants on contractility and fatigue of canine urethral sphincter.
Topics: Animals; Clenbuterol; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; Muscle C | 1994 |
Control of energy metabolism during muscle contraction.
Topics: Animals; Biological Transport; Bucladesine; Cells, Cultured; Clenbuterol; Creatine; Energy Metabolis | 1996 |
Effects of clenbuterol on rabbit vesicourethral muscle contractility.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Atropine; Clenbuterol; Electric Stimulation; Femal | 1995 |
Effects of clenbuterol on contractile and biochemical properties of skeletal muscle.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Down-Regulation; Female; Muscle Contraction; Muscle, | 1996 |
Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Clenbuterol; Histocytochemis | 1996 |
Effect of the beta-agonist clenbuterol on dexamethasone-induced diaphragm dysfunction in rabbits.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Dexamethasone; Diaphragm; Female; Glucocorticoids; M | 1996 |
Effect of clenbuterol on the modulation of noradrenaline release in the rat tail artery.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arteries; Clenbuterol; Dose-Response | 1996 |
Contractile properties of clenbuterol-treated mdx muscle are enhanced by low-intensity swimming.
Topics: Animals; Clenbuterol; Male; Mice; Mice, Inbred mdx; Muscle Contraction; Physical Conditioning, Anima | 1997 |
Differences between longitudinal and circular smooth muscle in beta-adrenergic control of motility of isolated equine ileum.
Topics: Adrenergic Agonists; Animals; Basement Membrane; Clenbuterol; Cyclic AMP; Dobutamine; Dose-Response | 1997 |
Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibers.
Topics: Adrenergic beta-Agonists; Animals; Caffeine; Calcium; Clenbuterol; Egtazic Acid; Muscle Contraction; | 1998 |
Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.
Topics: Administration, Oral; Animals; Clenbuterol; Disease Models, Animal; Heart; Male; Mice; Mice, Mutant | 1998 |
Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Electric Stimulation; Enzyme Inhibitors; Guanylate C | 1998 |
Long-term effects of clenbuterol on diaphragm morphology and contractile properties in emphysematous hamsters.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Cricetinae; Diaphragm; Male; Mesocricet | 1998 |
Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardiac assist.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Drug Evaluation, Preclinical; Electric | 1999 |
Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles.
Topics: Animals; Clenbuterol; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Skeletal; Organ Si | 1999 |
Suitability of the old fowl rectal caecum preparation for investigating the selectivity of beta-adrenergic drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Cecum; Chickens; Clenbuterol; Dobutami | 1998 |
Effects of beta(2)-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Calcium; Clenbuterol; Hindlimb Suspension; In Vitro | 2000 |
Uterine contractility is necessary for the clearance of intrauterine fluid but not bacteria after bacterial infusion in the mare.
Topics: Animals; Bacteria; Clenbuterol; Endometritis; Estrus; Female; Horse Diseases; Horses; Muscle Contrac | 1999 |
Inhibition of the contractile response of the rat detrusor muscle by the beta(2)-adrenoceptor agonist clenbuterol.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Carbachol; Clenbuterol; Electric Stimulat | 2000 |
Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Energy Metabolism; In Vitro Techniques; | 2000 |
Function and distribution of beta3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Clenbuterol; Female; Humans; Iodine | 2000 |
K(ATP) channels mediate the beta(2)-adrenoceptor agonist-induced relaxation of rat detrusor muscle.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Clenbuterol; Colforsin; Cyclic AMP; Cycli | 2000 |
A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Weight; Clenbuterol; Isometric Contraction; Male; Mus | 2000 |
Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Weight; Clenbuterol; Eating; Isometric Contraction; M | 2001 |
Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Diaphragm; Disease Models, Animal; Mice; Mice, Inbre | 2001 |
Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Male; Muscle Contraction; Muscle Denervation; Muscle | 2001 |
Biomechanical hearts: muscular blood pumps, performed in a 1-step operation, and trained under support of clenbuterol.
Topics: Animals; Biomechanical Phenomena; Blood Pressure; Clenbuterol; Goats; Male; Muscle Contraction; Musc | 2001 |
Inhibition of the contractile responses of isolated human and rat bladders by clenbuterol.
Topics: Adrenergic beta-Agonists; Aged; Animals; Chromatography, High Pressure Liquid; Clenbuterol; Enzyme-L | 2001 |
A farnesyltransferase inhibitor attenuated beta-adrenergic receptor downregulation in rat skeletal muscle.
Topics: Adrenergic beta-Agonists; Alkyl and Aryl Transferases; Animals; Animals, Newborn; Body Weight; Cells | 2002 |
Alteration of contractile force and mass in the senescent diaphragm with beta(2)-agonist treatment.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Water; Citrate (si)-Synthase; Clenbuterol; Diaphragm; | 2002 |
Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Drug Synergism; Growth Inhibitors; Interleukin-6; Le | 2002 |
Effect of clenbuterol on contractile response in periurethral striated muscle of rabbits.
Topics: Animals; Clenbuterol; Electric Stimulation; In Vitro Techniques; Isoproterenol; Male; Muscle Contrac | 1991 |
Effect of clenbuterol on normal and denervated muscle growth and contractility.
Topics: Animals; Clenbuterol; Denervation; Ethanolamines; Male; Muscle Contraction; Muscle Development; Musc | 1990 |
Pulmonary anti-anaphylactic activity of clenbuterol tested on actively and passively sensitized guinea-pigs.
Topics: Acetylcholine; Anaphylaxis; Animals; Bronchi; Clenbuterol; Ethanolamines; Female; Guinea Pigs; Hista | 1985 |
Effects of clenbuterol on resting tension and contractile response in vesicourethral smooth muscle of rabbits.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Atropine; Clenbuterol; Dose-Response Relationship, | 1989 |
Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of clenbuterol.
Topics: Animals; Carbachol; Clenbuterol; Ethanolamines; Guinea Pigs; Heart Ventricles; In Vitro Techniques; | 1985 |
The in vitro actions of clenbuterol (NAB-365) on bovine pulmonary vein and artery.
Topics: Animals; Cattle; Clenbuterol; Cyclic AMP; Ethanolamines; In Vitro Techniques; Muscle Contraction; Mu | 1985 |
Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist.
Topics: Animals; Butoxamine; Clenbuterol; Ethanolamines; Female; Isometric Contraction; Muscle Contraction; | 1988 |
Inhibition and reversal of denervation-induced atrophy by the beta-agonist growth promoter, clenbuterol.
Topics: Animals; Clenbuterol; Ethanolamines; Glycolysis; Male; Muscle Contraction; Muscle Denervation; Muscl | 1986 |
[Effect of the oral beta-mimetic drug clenbuterol (Contraspasmin, Spiropent) and orally and intravenously administered Partusisten on the rheobase].
Topics: Administration, Oral; Clenbuterol; Electric Stimulation; Ethanolamines; Female; Fenoterol; Humans; I | 1985 |